"Thyroid Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the THYROID GLAND.
Descriptor ID |
D013964
|
MeSH Number(s) |
C04.588.322.894 C04.588.443.915 C19.344.894 C19.874.788
|
Concept/Terms |
Thyroid Neoplasms- Thyroid Neoplasms
- Neoplasm, Thyroid
- Thyroid Neoplasm
- Neoplasms, Thyroid
Thyroid Carcinoma- Thyroid Carcinoma
- Carcinoma, Thyroid
- Carcinomas, Thyroid
- Thyroid Carcinomas
- Cancer of Thyroid
- Thyroid Cancers
- Thyroid Cancer
- Cancer, Thyroid
- Cancers, Thyroid
- Cancer of the Thyroid
Thyroid Adenoma- Thyroid Adenoma
- Adenoma, Thyroid
- Adenomas, Thyroid
- Thyroid Adenomas
|
Below are MeSH descriptors whose meaning is more general than "Thyroid Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Thyroid Neoplasms".
This graph shows the total number of publications written about "Thyroid Neoplasms" by people in this website by year, and whether "Thyroid Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 |
1995 | 8 | 7 | 15 |
1996 | 8 | 5 | 13 |
1997 | 7 | 3 | 10 |
1998 | 6 | 3 | 9 |
1999 | 11 | 0 | 11 |
2000 | 12 | 1 | 13 |
2001 | 11 | 1 | 12 |
2002 | 7 | 1 | 8 |
2003 | 21 | 0 | 21 |
2004 | 19 | 2 | 21 |
2005 | 28 | 3 | 31 |
2006 | 22 | 1 | 23 |
2007 | 32 | 3 | 35 |
2008 | 28 | 3 | 31 |
2009 | 32 | 1 | 33 |
2010 | 26 | 3 | 29 |
2011 | 24 | 8 | 32 |
2012 | 30 | 3 | 33 |
2013 | 35 | 5 | 40 |
2014 | 36 | 4 | 40 |
2015 | 41 | 6 | 47 |
2016 | 40 | 4 | 44 |
2017 | 40 | 2 | 42 |
2018 | 31 | 3 | 34 |
2019 | 28 | 3 | 31 |
2020 | 22 | 6 | 28 |
2021 | 24 | 0 | 24 |
2022 | 24 | 0 | 24 |
2023 | 19 | 0 | 19 |
2024 | 9 | 0 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thyroid Neoplasms" by people in Profiles.
-
Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors. Nat Med. 2024 Mar; 30(3):690-698.
-
Endocrine disrupting chemical mixture exposure and risk of papillary thyroid cancer in U.S. military personnel: A nested case-control study. Sci Total Environ. 2024 Apr 20; 922:171342.
-
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma. Cell Rep. 2024 Mar 26; 43(3):113826.
-
Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid. 2024 Mar; 34(3):336-346.
-
Thyroid Cancer: A Review. JAMA. 2024 02 06; 331(5):425-435.
-
Dynamics of The Gdtcr Repertoires During The Dedifferentiation Process and Pilot Implications for Immunotherapy of Thyroid Cancer. Adv Sci (Weinh). 2024 Apr; 11(13):e2306364.
-
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study. Thyroid. 2024 Mar; 34(3):347-359.
-
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers. Ann Surg Oncol. 2024 Apr; 31(4):2202-2203.
-
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study. Thyroid. 2024 01; 34(1):26-40.
-
Genomic alterations in thyroid cancer: biological and clinical insights. Nat Rev Endocrinol. 2024 Feb; 20(2):93-110.